Of interest, DCIS is a component of BRCA spectrum cancers, and BRCA2 carriers have higher incidences in DCIS compared to BRCA1 carriers [4], although DCIS is equally as prevalent in BRCA mutation carriers as in high familial-risk noncarrier women [4,5]. The gene discussed is BRCA1; the disease is ductal breast carcinoma in situ.